background: Meiotic progression, and the number of oocytes surviving to birth, determine the ovarian reserve, yet the control of prenatal oogenesis is poorly understood. We investigated the effects of genetic background and p53 upon oogenesis in mice.
Introduction
Factors controlling oocyte selection for the ovarian reserve are poorly understood. Early morphological studies in mice proposed that oocytes in certain stages of meiotic prophase I (MPI) had an increased likelihood of undergoing cell death. Particularly affected were oocytes at the pachytene and diplotene stages of MPI, from 18 days postcoitum (dpc) through to birth (Bakken and McClanahan, 1978) . More recently, with the aid of molecular markers, cell death has been observed throughout MPI (McClellan et al., 2003; Ghafari et al., 2007) ; however, the interaction between oocyte apoptosis and the normality and timeliness of meiotic progression remains poorly understood. This interaction may have important implications for the quality and quantity of oocytes produced prenatally.
Just as there are genetic influences over the age of menopause and other aspects of fertility in women, there may be differences in progression through MPI in mice with different genetic backgrounds (Peters, 1970; Koehler et al., 2002; Canning et al., 2003; McClellan et al., 2003; Ibáñez et al., 2005) . There are also contrasting reports about the extent of synchrony of the different stages of MPI (Crone et al., 1965; Wassarman and Albertini, 1994; Ghafari et al., 2007) , which arise from processes during oogenesis, to which genetic variation may also contribute.
p53 is a tumour suppressor gene that is a positive regulator of apoptosis in its native form (wild-type). DNA damage causes a rapid increase in the total concentration of p53 protein by increased gene transcription and the stabilization of normally rapidly degraded p53 protein which leads to the suppression of cell growth and p53-mediated cell-cycle arrest (Moallem and Hales, 1998) . This cellcycle arrest may provide more time for DNA repair to take place (Moallem and Hales, 1998) or be a prelude to apoptosis in lethally damaged cells (Smith and Fornace, 1996) . p53 is extensively expressed
Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology 2009. in many tissues during mouse embryogenesis (Moallem and Hales, 1998) , but total protein levels are low because of its relatively short half-life that averages about 20 min (Donehower et al., 1992) . The amount of p53 messenger RNA in developing mouse embryos is maximal on 9-11 days of gestation (Rogel et al., 1985) when the cells undergo terminal differentiation, after which the levels fall markedly (Schmid et al., 1991) . At this time, mouse primordial germ cells are also proliferating and preparing to differentiate into either oocytes or spermatocytes (Tanaka et al., 2000) . Therefore, we hypothesized that p53 could have an important role in the control of cell death in germ cells.
In male mice, p53 directly interacts with disruption of meiotic control (DMC1) in a cell-cycle checkpoint that detects chromosomal aberrations during MPI (Habu et al., 2004) . DMC1 deficiency leads to DNA double-strand break (DSB)-dependent oocyte loss during MPI (Di Giacomo et al., 2005) . Sturzbecher et al. (1992) showed that p53 also binds directly to human RAD51 and Escherichia coli RecA proteins, and the wild-type but not mutant form of p53 inhibited their function. These proteins are required for homologous recombination and repair of DNA DSB (Scully et al., 2000) , regulating the extent and timing of recombination (Gersten and Kemp, 1997) . The highest levels of p53 protein in the response to DSB caused by irradiation are observed in preleptotene spermatocytes in rat and pachytene spermatocytes in rat and mouse (Rotter et al., 1993; Sjö blom and Lähdetie, 1996) , the stage when DNA recombination occurs and DSB are also generated.
p53 protein also binds tightly to Holliday junctions, DNA structures formed during homologous recombination that facilitate junction resolution (Lee et al., 1997) . Holliday junctions are formed during pachytene and resolved into recombination by the diplotene stage (Kleckner, 1996) . The reported physical association of p53 with Holliday junctions and Rad51, as well as the expression of p53 in pachytene spermatocytes, may implicate p53 in the control of meiotic recombination. Matsui et al. (2000) showed that in p53 heterozygous fetuses resulting from C57BL6 Â CBA mice, p53 protein increased on 15.5 dpc in fetal testes but was not detected in fetal ovaries. On 16.5 dpc, there was no significant difference between the numbers of apoptotic cells in seminiferous tubules in wild-type and p53-deficient fetal testes, but on 17.5 dpc more apoptotic cells were observed in wild-type testes. In contrast, similar numbers of apoptotic cells were found in fetal ovaries throughout these developmental stages. However, Gersten and Kemp (1997) reported no biologically significant differences in meiotic recombination frequencies in p53 knockout mice resulting from C57Bl6 Â C3HF1 compared with the control. This may have resulted from differences in the genetic characteristics of animals used.
In somatic cells, intracellular death signals, such as genome instability, induce p53 gene activation, which leads to activation of either Bax or Fas pathways resulting in activation of caspase-3 and/or -7, which then leads to inactivation of poly-(ADP-ribose) polymerase 1 (PARP-1) and consequently apoptosis (Simbulan-Rosenthal et al., 1999) . After PARP-1 cleavage by caspase-3 and/or 7, the N-terminal fragment of PARP-1 retains a strong DNA binding activity and totally inhibits the catalytic activity of uncleaved PARP-1 (D' Amours et al., 2001 ), which will result in the activation of p53 and apoptosis.
It is well known that abnormal germ cells are eliminated mainly through apoptosis, however, the role of p53 in apoptosis due to genome instability during female meiosis is controversial. To date there are no reports about the role of p53 gene on the formation of synaptonemal complexes (SCs) during oocyte progression or oocyte elimination at different stages of MPI. In the studies reported here, we investigated the effect of genetic background on SC formation in three generations of hybrid mice. We also investigated the occurrence of apoptotic cell death in fetal oocytes of p53 knockout mice to explore the relationship between p53 gene and oocyte apoptosis during MPI. Our previous studies report the use of a fluorescent immunocytogenetic method to stage fresh and cultured oocytes in MPI Hulten, 1996, 1997; Hartshorne et al., 1999; Tease et al., 2002) . This method supports detailed analysis of chromosomal synapsis, which can be interpreted in relatively large numbers of cells to obtain data on the progress of MPI in oocyte populations, and so was a useful approach for the current study.
Materials and Methods

Chemicals
All chemicals were purchased from Sigma (Dorset, UK) unless otherwise stated. Anti-synaptonemal complex protein 3 (SCP3) primary antibody, raised in rabbits, which predominantly recognizes SCP3, was a gift from Christa Heyting (Wageningen University, The Netherlands). Anti-Cor1 antibody was a gift from Barbara Spyropoulos (York University, Toronto, Canada). Anti-cleaved PARP-1 antibody was purchased from Cell Signalling (Danvers, MA, USA). All secondary antibodies were purchased from Vector laboratories (UK). The kit for terminal deoxynucleotidyltransferase-mediated dUTP nick-end labelling (TUNEL) was purchased from Intergen, UK.
Animals
All mice were kept and bred under Home Office licence, housed at 238C with 12:12 h of light:dark and fed ad libitum. Three types of mice were used: (i) B6CBf1, produced by crossing C57Bl6 female with CBA male; (ii) B6CBf2, the f2 generation produced by crossings of adult male and female B6CBf1 mice; (iii) p53 knockout (p53 2/2 ), heterozygous (p53 þ/2 ) and wild-type (p53 þ/þ ) mice, originally B6CBf2-f6 generations.
The f1 and f2 generations were originally selected for comparison because we hypothesized that the maternal genetic environment might affect fetal oogenesis and we expected to rule this out by our analysis. Additionally, we analysed f2 oocytes with a view to providing baseline data for the p53 mice. p53 knockout animals were originally produced by introducing a targeting vector (containing 3.7 kb of the genomic p53 gene interrupted in exon 5 by a Pol II-'neo' expression cassette accompanied by deletion of a 450 base pair (bp) p53 gene fragment containing 106 nucleotides of exon 5) into 3.5-day C57Bl6 blastocysts (Donehower et al., 1992) . These blastocysts were implanted into pseudo-pregnant B6CBF1 mice (Donehower et al., 1992) . p53 mice of all genotypes were used before 6 months of age.
To ensure precise dating of pregnancies, male and female mice were housed together overnight for one night only. Females were checked early the following morning. If a copulation plug was observed, this time was considered as day 0.5. Pregnant f1 and f2 females were sacrificed in a CO 2 chamber on specific dpc in the morning (15.5 dpc) or evening (16, 17, 18, 19, 20 and 21 dpc Influence of genotype and p53 on prenatal oogenesis were used in these investigations. The number of fetuses in each category was dependent on the number of females among the litters from adult pregnant mice at different dpc (Table I) .
Breeding p53-deficient mice
The mating of p53 mice was carefully controlled to produce fetuses on planned dates to study SCP3 and apoptosis. Mice were only caged together overnight to ensure accuracy of dating and often did not mate, but they were not housed together again unless it was clear that the female was not pregnant. Obtaining adult and fetal mice with the genotypes of interest was therefore time-consuming, and regular genotyping of new stock was required. Hence, SCP3 formation in p53 mouse fetal oocytes was studied only on 15.5 and 16 dpc when many oocytes are at the zygotene and pachytene stages of MPI.
In total, on 15.5 dpc, 28 fetuses resulted from 8 crossings, and on 16 dpc, 41 fetuses resulted from 10 crossings. The genotypes are presented in Table I .
p53 genotyping
Adult p53 mice had their tails snipped under local anaesthesia. Samples of tail and limb tissues of each fetus were collected separately in labelled sterile tubes at the time when the ovaries were dissected. Genotyping was carried out by PCR (Timme and Thompson, 1994) . Three primers were used: p53 wild-type forward primer: 5 0 GTG GGA GGG ACA AAA GTT CGA GGC C 3 0 , product length: 550 bp. p53 null forward primer: 5 0 TCT CCT GTC ATC TCA CCT TGC 3 0 , product length: 650 bp. The p53 reverse primer: 3 0 ATG GGA GGC TGC CAG TCC TAA CCC 5 0 was used with both of the forward primers.
Collection and preparation of mouse fetal/ neonatal ovarian tissues
Collection and preparation of ovarian tissues has been previously described (Ghafari et al., 2007) . Briefly, ovaries were dissected from female fetuses between the ages of 14.5 and 18 dpc or neonates at 19 -21 dpc. Ovaries from B6CBf1 and B6CBf2 fetuses/neonates and p53 mouse fetuses at each time point were placed in protein-free Ham's F10 medium. The ovaries of each fetus/neonate were kept separate. To obtain microspread oocyte preparations, individual whole ovaries were macerated in protein-free Ham's F10 medium on an ethanol-cleaned glass slide and further prepared as described below. One ovary was used per slide. For B6CBf1 and f2 fetuses/neonates, both ovaries were analysed in order to assess the variation between preparations that could be ascribed to technical factors.
Determination of stages of MPI using SCP3
Oocytes in MPI were identified by labelling SCP3, a meiosis-specific protein which is present on the lateral and axial elements, using a method already well established in our laboratory (Barlow and Hulten, 1996; Hartshorne et al., 1999; Tease et al., 2002; Ghafari et al., 2007) . Briefly, each ovary was dispersed on a slide, and the cells were treated with 3% of sucrose hypotonic solution for 30 min at room temperature and fixed in 1% of ultra pure formaldehyde (TAAB, Aldermaston, UK) containing 2% of sodium dodecyl sulphate, pH: 8.4 for 20 -30 min at room temperature. After fixation, all slides were washed for 5 min with dH 2 O, permeablized with 0.1% Triton X-100 in phosphate-buffered saline (PTB) and incubated for 45 min in 5% normal goat serum before overnight incubation in anti-hamster SCP3 antibody (1:1000 dilution) followed by washing in PTB and incubation in Texas Red conjugated goat anti-rabbit antibody (1:200 dilution) for 30 min in the dark at 378C. 
Total number of fetuses The numbers of fetuses (and neonates) examined on different dpc and the number of ovaries dissected from each fetus/neonate are presented for B6CBf1 and B6CBf2 and p53 mouse crossings. The genotypes examined are presented in parentheses.
p53 wild-type: p53
(4,6-diamidino-2-phenylindole) and examined using a fluorescence microscope (Axioskop, Carl Ziess). Fluorescence microscope images of individual oocytes were recorded by image analysis via a cooled charged-coupled device camera and Vysis QUIPS with Smart capture software (Digital Scientific). Negative controls lacking primary and/or secondary antibodies were performed at the same time as test slides to confirm specificity of staining. Total numbers of oocytes (considered as cells that showed SCP3 staining of axial elements) were counted on each slide prepared from one fetal/ neonate ovary. Each oocyte was classified as in a specific stage of MPI according to the appearance of its axial elements using established criteria (Barlow and Hulten, 1996) as described previously (Ghafari et al., 2007) .
To examine the effect of genetic background and p53 on oocyte apoptosis during MPI, we used immunocytochemistry of cleaved PARP-1 and TUNEL for DNA DSBs, as markers for apoptosis or cell death. Cleaved PARP-1 is a specific marker of apoptosis, whereas TUNEL is a commonly used indicator of DNA damage associated with cell death. The use of these techniques for the analysis of apoptosis in fetal oocytes was as previously described (Ghafari et al., 2007) .
Criteria for classification of oocytes
The oocytes identified by SCP3 labelling were classified into different categories according to the stage of meiosis and the nature of labelling observed (intact or fragmented). The categories have been previously described in detail for COR-1-stained oocytes (Ghafari et al., 2007) , whereas the allocation to different meiotic stages has been described for oocytes labelled with SCP3 ( Fig. 1A -D ; Hartshorne et al., 1999; Tease et al., 2002) . Briefly, in the leptotene stage, the chromosomes condense and axial elements form between the chromatids of parental chromosomes. The anti-SC antibody gives a thin linear signal alongside the chromatids in regions where the axial elements have formed. In the zygotene stage, homologous chromosomes start to synapse with the formation of SC, observed with anti-SC antibody as a signal of double thickness along the synapsed part of the bivalent. In the pachytene stage, the homologous chromosomes are completely synapsed, resulting in 23 linear signals of double thickness in humans and 20 linear signals in mice. In the diplotene stage, the SC break down and the homologous chromosomes separate, except where chaismata exist. Oocytes in the leptotene stage were considered normal because the elements were expected to appear fragmented at this time.
Oocytes categorized as 'compressed' were not well-spread on the slide, and so could not be allocated to a meiotic stage. Our previous studies show that such oocytes are more likely to carry apoptotic markers, and become prevalent from birth, around 19 days (Ghafari et al., 2007) . We include them in our calculations because they are quantitatively a significant group, and their omission, based upon the suboptimal response to the Figure 1 Photomicrographs of microspread mouse oocytes. Mouse oocytes stained for SCP3 (red) in leptotene (A and B), zygotene (C), late zygotene with fragmented axial elements (arrowheads) (E) and pachytene (D, top image) and very late diplotene (D, lower image) stages. Unstaged oocyte with twisted, mostly unsynapsed axial elements indicated with white arrows (F). Oocyte with degenerated axial elements clearly stained but barely distinguishable from each other (G), compressed axial elements in three oocytes each indicated with a white 'o' (H). Only B includes 4 0 ,6-diamidino-2-phenylindole (DAPI) counterstaining. COR1 (red) staining of a TUNEL-positive (green) oocyte in zygotene (I and J) and a pachytene oocyte positive for both cleaved poly-(ADP) ribose polymerase 1 (PARP-1, blue) and TUNEL (green) (K).
Influence of genotype and p53 on prenatal oogenesis spreading technique, may result in a misrepresentation of the dynamics of cell death within the fetal ovary. Oocytes in Fig. 1E -H show a variety of abnormal features. Degenerated oocytes were those with severely fragmented axial elements where no stage could be determined.
Oocytes stained for cleaved PARP-1 and TUNEL were individually classified as either positive or negative for each marker, resulting in groups:
Statistical analysis
The variables of interest to us in this study consisted of the proportions of oocytes occupying various stages in MPI (from preleptotene to diplotene). These data were observed for five genotypes: f1, f2 (at seven ages between 15.5 and 21 dpc) and p53 wild-type, heterozygote and knockout (at two ages between 15.5 and 16 dpc). To study the effect of genetic background on the progress of the oocytes through the various stages, logistic regression was used. This analysis was applied to proportions occupying particular stages, and also to the proportions attaining at least the relevant stage. This latter type of cumulative analysis was found to be more effective in highlighting the differential rates of progress through the stages. Although all the analyses were conducted on the logistic scale, the final results will be presented as proportions. Now, for any genotype, the proportions of meiotic stage (preleptotene, etc.) are not independent in that their sum will by definition be 1.0. In order to combine these proportions, therefore, to provide a composite picture, the multivariate technique of canonical variate analysis was used. This involved calculating that linear function of the meiotic stage proportions which maximized the separation of the genotypes. The magnitudes of the coefficients so calculated indicate the relative importance of the stage in discriminating between the genotypes, and the function values obtained by applying the coefficients indicate the separation of the genotypes.
Results
Summary of materials analysed
The numbers of female fetuses at each dpc, derived from different mouse crossings, and their genotypes, are presented in Table I .
Examples of mouse oocytes at different stages of MPI, microspread and stained for SCs, cleaved PARP-1 and/or TUNEL are presented in Fig. 1 .
SCP3 staining in B6CBf1 and f2 fetal oocytes
Comparison of the numbers of oocytes isolated from left and right ovaries For all B6CBf1 and f2 mice in which data from both ovaries were available, the total numbers of oocytes from ovary 1 (left) versus ovary 2 (right) were compared (Fig. 2) . There was a highly significant positive correlation between total numbers of oocytes isolated from ovary 1 and ovary 2 for both B6CBf1 and f2 mice (combined P , 0.0001, r ¼ 0.83), confirming that the technical process of oocyte preparation did not introduce significant variability to the data sets.
The numbers of oocytes at particular stages of meiosis in the two ovaries of each fetus or neonate of B6CBf1 and f2 mice were also compared. The number of oocytes at different stages of MPI, as a proportion of total number of oocytes in the same ovary, has been presented separately for oocytes with intact or fragmented staining of axial elements. The numbers and proportions of oocytes in each fetus and neonate at different stages of MPI were generally similar for the two ovaries of one mouse. However, there were some occasional discrepancies, for example, in B6CBf1 on 16 dpc in fetus 3 and on 17 dpc fetus 1 (see Supplementary Information, Appendix 1). Variation between ovaries was less than that between mice.
Comparison of B6CBf1 and f2 mice in terms of progression of MPI Apparent differences between f1 and f2 generations in terms of the distribution of oocytes in MPI prompted us to undertake a multivariate statistical analysis. Nested mixed linear model analysis showed that there are significant interactive effects of fetus type (f1 and f2), dpc, subjects (each fetus/neonate) and ovaries on the total number of oocytes at different stages of MPI (P , 0.0001).
Effect of genetic background on progression of meiosis in oocytes
The temporal distribution of f1 and f2 oocytes at particular stages of MPI is presented in Fig. 3 . On average, oocytes in f1 fetuses were almost 1 day ahead of f2 oocytes. Statistical analysis using the general linear model and multivariable tests showed that the f1 and f2 preparations were significantly different in the total number of oocytes with intact axial elements at leptotene (P , 0.001), pachytene (P , 0.002) and also the total numbers of oocytes with unstaged (compressed and fragmented; P , 0.01) and degenerated (P , 0.01) axial elements. Table II shows the differences in the probability of B6CBf1 and f2 oocytes being in different stages of MPI. The table should be read by column pairs, so that differences in the distributions for B6CBf1 and f2 may be appreciated. In order to highlight this feature, a weighted mean of the day number was computed, the weighting factor being the proportions. Thus, for oocytes, the average day number for the zygotene stage was 16.0 for f1 and 16.9 for B6CBf2. The P-value at the foot of the table relates to the interaction of genotype and day number, a significant P-value indicating differences in the pattern of column proportions. This same trend was observed for leptotene, and pachytene, where the average day for B6CBf2 was higher than for B6CBf1. When the data were analysed using prediction from a regression model, for instance, all proportions in B6CBf1 mice reduced dramatically with age (Table II) . Zygotene oocytes in B6CBf1 mice seemed to be very rare in 19 dpc and by 20 and 21 dpc these oocytes have not been observed at all, whereas the effect is less pronounced for B6CBf2. This is the reason for the significant interaction effect between B6CBf1 and f2.
In addition, there was some indication of a second wave of MPI occurring around 18-19 dpc in f2 oocytes when the proportions of show two waves of oocyte development at different time points during MPI. There was a high proportion of zygotene oocytes in 15.5 dpc in f1 ovaries but on both 15.5 and 18 dpc in f2. A similar trend was observed in pachytene and diplotene oocytes, where two waves of oocyte progression were apparent at different time points depending on the genetic background of the mice.
Influence of genotype and p53 on prenatal oogenesis zygotene increased transiently, associated with slight increases in f2 leptotene and pachytene oocytes around the same time (Fig. 3) . Oocytes with intact and fragmented axial elements were plotted separately; however, this did not reveal any material difference in their development (data not shown). Oocytes having fragmented axial elements comprised a minority of the total population of oocytes, confirming our previous data (Ghafari et al., 2007) . The observed distribution remained consistent. One unexpected finding was that the numbers of diplotene oocytes fluctuated over the period observed, rather than increasing consistently as might be expected. Our previous data have shown that the diplotene stage is particularly affected by apoptosis. We also note that the 'compressed' category does increase with time, so it is possible that oocytes that are either tightly constrained by follicular cells or are undergoing apoptotic changes are less able to expand. Thus, the number of diplotene oocytes that we recorded might predominantly reflect the viable, non-follicle-enclosed population.
p53 mouse oocytes differ from B6CBf1 and f2 mouse oocytes during MPI SCP3 staining was studied in a total of 2953 oocytes from 28 p53 fetuses on 15.5 dpc, and 6510 oocytes from 41 p53 fetuses on 16 dpc arising from six different types of p53 mouse matings. Several significant differences were observed in the proportions of oocytes between B6CBf1 and f2 mice and p53 mice (see Table III ), but the overall pattern was not straightforward. At 15.5 dpc, genotypes B6CBf2 and p53 þ/2 appeared to be the most advanced, as evidenced by the relatively high proportions of pachytene and diplotene oocytes, and the negative function value. The final column in Table III defines this function, and effectively it is seen to be the difference between the first three stages (preleptotene, leptotene and zygotene) and the remaining two (pachytene and diplotene) stages. This interpretation includes oocytes in leptotene, zygotene, pachytene, diplotene stages and the oocytes in other categories, e.g. oocytes with unstaged axial elements. The relatively high function value of 2.10 denotes the retarded genotype p53 wild-type, with relatively high proportions of preleptotene and leptotene oocytes on 15.5 dpc. However, at 16 dpc, the situation had changed with p53 þ/2 and p53 2/2 mice showing the greatest function value and hence overall retardation. The differential progress of the various genotypes through the stages of meiotic prophase is illustrated in Fig. 4 . The proportions plotted are cumulative proportions, so that they represent estimates of the probabilities that the oocytes will attain at least the stages given on the horizontal axis. This method of presentation highlights genotype differences rather better than would a plot of the proportions actually occupying each meiotic stage. Since the natural progression is from the preleptotene through the diplotene stage, all the plotted lines decline from left to right. A speedy passage through the meiotic stages is represented by the genotype line being relatively high up on the plot. Thus, at 15.5 days, the f2 genotype had progressed faster than any of the others. Conversely, at 16 days, the p53 2/2 genotype had progressed slower than the remaining genotypes. Among the p53 genotypes, oocytes from p53 2/2 fetuses seemed to be more advanced entering most stages of MPI (leptotene, zygotene and diplotene) on 15.5 dpc. However, this was reversed by day 16 when p53 2/2 oocytes were slowest, particularly in reaching the pachytene and diplotene stages and contained fewest oocytes in all stages of MPI. p53 2/2 oocytes also exhibited further differences in comparison with oocytes from other genotypes: first, they showed the highest probability of oocytes with compressed axial elements (Table IIIB included under 'rest') and second, they contained the lowest numbers of diplotene oocytes (both intact and fragmented) on 16 dpc (Table III) . These differences together may show that the absence of p53 gene influences the entry into and progression through MPI. p53 2/2 and p53 þ/2 fetal oocytes (respectively) contained a significantly higher proportion of abnormal oocytes compared with oocytes from other genotypes (P , 0.001, Fig. 5 ). This may suggest that p53 gene is involved in the regulation and selection of oocytes at checkpoints, such that oocytes that would otherwise be lost may persist when p53 is absent or reduced. 
PARP-1 and TUNEL labelling in p53 mouse fetal oocytes
Assessment of apoptosis and DNA fragmentation in p53 mouse oocytes
To investigate the effect of genetic background and the role of the p53 gene in oocyte apoptosis, the presence of cleaved PARP-1 and DNA DSB was assessed in 367 oocytes of p53 mice on 16 dpc when many oocytes are at the pachytene stage. These nine fetuses resulted from three sets of matings between p53 Figure 6 shows the proportions of oocytes from p53 fetuses showing cleaved PARP-1 and/or TUNEL staining. Oocytes with intact axial elements in p53 þ/þ fetuses showed similar proportions in all categories of PARP-1 and TUNEL detection (
) on 16 dpc from preleptotene to diplotene (Fig. 6A ). p53 2/2 oocytes had a distinctly different profile of PARP-1 and TUNEL staining to p53 þ/þ oocytes, the majority were in zygotene and negative for PARP-1 and TUNEL staining and few were P 2 T þ , in contrast to p53 þ/þ fetuses where similar proportions of all PT categories were evident. Oocytes from p53 þ/2 fetuses showed an intermediate pattern. Oocytes with fragmented axial elements were present at very low proportions in all categories of PARP-1 and TUNEL staining in all fetuses.
Discussion
The factors controlling the quantity and quality of oocytes that survive prenatal selection are poorly understood. The maximum population theoretically available for oogenesis is the number of oogonia formed. Oogonia are diploid cells resulting from mitosis of primordial germ cells, which then enter meiosis and can no longer proliferate. In mice, around 40% of the germ cells formed prenatally remain at birth (Burgoyne and Baker, 1985) , and thus the majority are removed from the potential gamete pool. A range of mechanisms contribute to this selection process, including, for example: † survival factors that promote mitosis and migration of primordial germ cells, or whose absence predisposes to cell death (see Driancourt et al., 2000; De Felici et al., 2005) ; † failure of some oogonia to enter meiosis (Wartenberg et al., 2001; Bowles and Koopman, 2007) ; † MPI, an error prone process, involving both synapsis of homologous chromosomes and recombination, during which many oocytes are known to acquire meiotic abnormalities and cease further development (Mittwoch and Mahadevaiah, 1992) Significant. NS: non-significant. † recruitment of somatic pre-granulosa cells to form the primordial follicle, which appears to be limited by the availability of somatic cells, such that some oocytes do not recruit sufficient supporting cells and consequently degenerate (Guigon and Magre, 2006) .
Moreover, many of the above mechanisms progress in parallel. Although there are regional differences in, for example, the timing of entry into meiosis across the ovary (Byskov et al., 1997) , adjacent cells may be undergoing different processes simultaneously (Pepling and Spradling, 2001) . How the responses of individual cells to local molecular signals translate into the coordinated generation of the population of post-natal oocytes is unclear. Some progress has been made towards identifying the signals involved (Morita and Tilly, 1999; Alton and Taketo, 2007) , but little is known about the influence of genetic strain upon fertility mediated through prenatal oogenesis. In this study, we present several novel findings that aid in identifying factors that influence prenatal oocyte progression through MPI. Such factors have underlying importance in controlling the number and quality of oocytes comprising the ovarian reserve at birth.
(1) Significant differences in the rate of oocyte progression through MPI in B6CBf1 and f2 generations. (2) Significant differences between p53 2/2 oocyte populations and those with the p53 gene present, in terms of (i) the proportion of oocytes that reached specific stages of MPI on 15.5 and Figure 4 Graphical illustration of the progress of the genotypes through the meiotic prophase stages at 15.5 days and at 16 days. The cumulative proportions plotted thus represent the probabilities that the oocytes will attain at least the stage given on the horizontal axis. f1: B6CBf1; f2: B6CBf2; WT: p53 wild-type (p53 þ/þ ); HET: p53 heterozygous (p53 þ/2 ); KO: p53 knockout (p53 2/2 ).
Figure 5
Proportion of oocytes with abnormal axial elements in different genotypes during MP1. The estimated proportion abnormal, together with the 95% confidence limits, is presented for each genotype. There was overwhelming evidence (P , 0.001) that the incidence of abnormalities varied over genotype. It is clear from the non-overlap of the 95% confidence limits that the main deviations arose from the very low incidence for 'wt' and the relatively high figures for both 'het' and 'ko'. Lack of p53 gene in ko and het mice was therefore associated with increased proportions of oocytes with abnormal axial elements. p53 wt had proportions of abnormal oocytes similar to the ancestors, B6CBf1 and f2 mice. F1: B6CBf1; F2: B6CBf2; wt: p53 wild-type (p53 þ/þ ); het: p53 heterozygous (p53 þ/2 ); ko: p53 knockout (p53 2/2 ). Figure 6 The proportions of oocytes in different categories of cleaved PARP-1 and TUNEL labelling in p53 fetal ovaries resulting from different crossings. There are lower proportions positive for cleaved PARP-1 and/or both cleaved PARP-1 and TUNEL among oocytes from p53 heterozygous and knockout fetal ovaries than wild-type. P þ indicates positive and P 2 indicates negative for cleaved PARP-1, respectively. T þ indicates positive and T 2 indicates negative for TUNEL, respectively. Each oocyte was scored for both markers, giving four possible categories:
These data arise from nine fetuses resulting from three sets of matings between p53
Influence of genotype and p53 on prenatal oogenesis 16 dpc and (ii) the proportion of oocytes having observed abnormalities in SCs. (3) Significant differences in the presence of cleaved PARP-1 (an apoptosis marker) and TUNEL (a marker of DNA DSBs) in p53 2/2 , p53 þ/2 and p53 þ/þ mice.
(4) In addition, we have confirmed the same lack of association of SC fragmentation with apoptosis in p53 mice that we have reported previously in B6CBf1 mice (Ghafari et al., 2007) .
Oocyte progression through MPI
Our observed differences between B6CBf1 and f2 generations of mice highlight the importance of genetic background for entry into and progression through MPI. The evidence presented supports our previous finding that mouse oocytes enter MPI at a pace that is affected by genetic background (Ghafari et al., 2007) and supports others who showed an effect of mouse strain upon meiotic progression (Peters, 1970; Canning et al., 2003; Ibáñez et al., 2005) . In the present study, oocytes with intact axial elements in f1 mice were advanced in their development by 1 day ahead of f2 mice at leptotene and zygotene. Later, the pattern of oocytes at pachytene and diplotene become more complex; however, the progression of oocytes during MPI remained significantly different in f1 and f2 mice, influenced by the stage, dpc and genotype as well as between individual mice. Our tentative evidence of an additional wave of MPI in f2 female mice is in agreement with reports in rats (Pujol et al., 1988; Wartenberg et al., 1998) . The precise genetic elements responsible for these differences have not been addressed in our study and are worthy of further investigation.
Impact of p53 knockout upon oogenesis
The role of p53 in oocytes is controversial, although its importance in both somatic cells and male meiosis is well recognized (Sjö blom and Lähdetie, 1996; Moallem and Hales, 1998; Odorisio et al., 1998) . p53 is a crucial regulator of genetic integrity, involved in recognizing DNA damage and eliminating lethally damaged cells via cell-cycle arrest and apoptosis (Hussein, 2005) . p53 is one of a family of transcription factors, also including p63 and p73, with isoform variants, that are involved in ensuring genome integrity and tumour suppression. In the testis, p53 facilitates DNA repair during spermatogenesis and controls the premeiotic checkpoint (Schwartz et al., 1999) . Thus, it is logical to examine its potential involvement in prenatal oogenesis. However, relevant literature on females is sparse. Murdoch et al. (2003) found that p53 in fetal oogonia was up-regulated by oxidative stress due to underfeeding pregnant ewes, a treatment which was also associated with delayed progression to arrest in the diplotene stage of MPI. However, the tissue concentrations of oocytes and the levels of apoptosis (assessed by TUNEL) were not affected. They suggested that oxidative stress prompts DNA damage, cell-cycle delay, anti-apoptotic and repair responses. However, TUNEL may not be a good indicator of apoptosis in oocytes (Ghafari et al., 2007; De Felici et al., 2008) .
It has been demonstrated in a variety of ways that oocyte death can occur via p53-independent mechanisms, for example, in the response to DNA damage resulting from chemotherapy (Suh et al., 2006) ; however, the potential for a role of p53 in oocyte selection or death has not been eliminated. Likewise, mice lacking p53 gene showed a similar rate of oocyte loss in response to induced DNA damage as wild-type mice (Perez et al., 1997) . However, the response to extensive DNA damage induced by chemotherapy, starvation or other interventions may differ from that under normal conditions of oogenesis, where a lower background level of DNA damage may be anticipated and where DNA DSBs are present as an essential component of meiosis (Valerie and Povirk, 2003) . Supporting this concept, oogenesis in p63 null mice was reported to be similar to that of wild-type mice, despite such oocytes showing divergent responses to damage induced by irradiation (Suh et al., 2006) . p63 has been shown to be present in mouse oocytes from 18.5 dpc (late pachytene to diplotene oocytes); however, no immunohistochemical signal was observed for p53 in small non-growing oocytes 8 days post-partum, in contrast to large growing oocytes which displayed a strong signal (Livera et al., 2008) . Interestingly, our results show effects of p53 genotype from early MPI, which may imply transient or low-level p53 protein that may be below the threshold for detection by immunohistochemistry. At 15.5 dpc, we observed that the appearance of axial elements of p53 2/2 and p53
oocytes showed high levels of zygotene, pachytene and diplotene stage oocytes in comparison with p53 þ/þ (wild-type). By 16 dpc, this trend was reversed with p53 2/2 mice having fewer oocytes in all defined stages of MPI (Fig. 4) . This information may be interpreted to suggest that the presence of p53 may slow the attainment of leptotene, zygotene and pachytene stages, possibly due to its function in checking for genetic integrity. However, at 16 dpc, absence of p53 seems to have had an impact upon the persistence of oocytes in each stage, the proportions being lower relative to those oocytes having p53 present. It may be hypothesized that some oocytes had continued through meiosis at a faster rate and thus were lost from the gene pool more readily than for wild-type or p53 þ/2 . Interestingly, and possibly in support of this idea, a larger proportion of 'compressed' oocytes were found in p53 2/2 ovaries on day 16 (Table III) .
Such oocytes are more commonly found towards the later stages of MPI from 18 days onwards (Fig. 3) . Moreover, Fig. 6 shows that, at 16 dpc, p53 2/2 mice were less likely to show the apoptotic marker cleaved PARP-1, and TUNEL, which marks DNA breaks, thus suggesting that oocytes may have progressed further and faster, in the absence of p53 gene, due to lack of active hindrance by p53 checkpoint functions and the onset of apoptotic mechanisms and DNA degradation. Lee et al. (1997) showed that p53 protein binds tightly and specifically to synthetic Holliday junctions. Holliday junctions are formed during the pachytene stage of MPI and are resolved into recombination by the diplotene stage (Valerie and Povirk, 2003) . Our earlier studies showed that apoptotic oocytes were dominant during the diplotene stage in mice, although apoptosis could occur throughout MPI (Ghafari et al., 2007) . Therefore, our findings may be consistent with the idea that if p53 is present during pachytene then oocytes which are incapable of continuing meiotic division due to non-resolved Holliday junctions are eliminated by apoptosis as they enter diplotene stage. The presence of high levels of compressed oocytes in p53 þ/2 and p53 2/2 fetuses at 16 dpc may indicate the consequence of the absence or low level of p53 in oocytes leading to continued cell cycle with insufficient time for DNA repair, similar to its effect in somatic cells (Moallem and Hales, 1998) . Further investigation will be necessary to test these ideas and refine the data; however, the highly significant differences that we have detected between mice of different genotypes do suggest a role for p53 in prenatal oogenesis. We also noted that progress through MPI for p53 wild-type oocytes was slower than for B6CBf2 oocytes, their genetic background mice. Reasons for this may include the use of generations beyond f2 for p53 mouse breeding and divergence of strains over time. However, it further underlines the effect of genetic factors upon oogenesis.
PARP-1 and TUNEL in relation to p53 genotype
We have previously used cleaved PARP-1 and TUNEL as markers to detect apoptosis in oocytes and to assess the relationship of apoptosis with DNA DSBs highlighted by TUNEL. PARP-1 and p53 interact during apoptosis in somatic cells because p53 is one of the earliest targets for poly-(ADP-ribos)ylation (Simbulan-Rosenthal et al., 1999) . p53 also enhanced recombination in somatic cells in vitro unless DNA DSBs were present, in which case the enhancement was no longer evident (Baumann et al., 2006) . PARP-1, therefore, prevented p53-stimulated spontaneous homologous recombination (Baumann et al., 2006) . The extent to which these mechanisms also operate in meiotic cells is uncertain. Our study showed that a significantly different profile of PARP-1 and TUNEL staining was present at day 16 in oocytes at different stages of meiosis from mice of different p53 genotypes (Fig. 6 ). In particular, the p53 2/2 mice had significantly more oocytes that were unstained for both PARP-1 and TUNEL, along with lower proportions stained for either PARP-1 or TUNEL alone. This would be consistent with the idea that p53, when present, is a positive regulator of apoptosis in oocytes during MPI, in accord with its role in somatic cell types (Moallem and Hales, 1998; Sakamaki, 2003) . The roles of p53 in apoptosis and cell-cycle arrest are separable under certain circumstances (Rowan et al., 1996) and apoptosis may be p53 dependent or independent. Indeed the pathways of apoptosis in response to a DSB stimulus vary according to the origin of the DSB (Valerie and Povirk, 2003) and numerous pathways seem to be operational in the ovary (De Felici et al., 2008) . Given the importance of oogenesis for survival of the species, p53 may be just one of a number of mediators of apoptosis that respond to certain stimuli via different inter-related pathways, to maintain the quality and quantity of the eventual ovarian reserve.
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